chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Weakness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced ASTHENIA (Weakness). On 03-Mar-2021, ASTHENIA (Weakness) had resolved. Not Provided          No concomitant medications were reported. No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
visual disturbances/blurry section in his visual field on both eyes; This spontaneous case was reported by a physician and describes the occurrence of VISUAL IMPAIRMENT (visual disturbances/blurry section in his visual field on both eyes) in a 65-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     Patient was in good health.     On 20-Sep-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 21-Sep-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced VISUAL IMPAIRMENT (visual disturbances/blurry section in his visual field on both eyes). On 21-Sep-2023, VISUAL IMPAIRMENT (visual disturbances/blurry section in his visual field on both eyes) had resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter considered VISUAL IMPAIRMENT (visual disturbances/blurry section in his visual field on both eyes) to be related.    Concomitant product use was not provided by the reporter.  It was reported that patient go the new covid-19 vaccine yesterday.  This morning 21-Sep-2023 he had about 10 minutes of visual changes, which resolved on its own.it was blurry section in his visual field on both eyes. Reporter stated that patient received the new monovalent 2023-2024 Formula. He did not had the lot number. He confirms it's the Spikevax, the newest one.  Reporter also stated that there was talk about an increased risk of thrombosis or thrombotic events back in 2020. However, reporter was talking about Spikevax as a 2-dose series.  Treatment information was not provided.  The reporter states he was concerned that the visual disturbances might had been a transient ischemic attack that was caused by the vaccine.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 55-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EJ1686), on 12Feb2021 as dose 2, single (Lot number: EL1283), on 21Oct2021 as dose 3 (booster), single (Lot number: FF8839) and on 20Apr2022 as dose 4 (booster), single (Lot number: PJ4989) at the age of 55 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "over weight" (unspecified if ongoing); "asthma" (unspecified if ongoing); "sinus tachycardia" (unspecified if ongoing). Concomitant medications in 2 weeks included: EFFEXOR; SYNTHROID; VITAMIN D NOS; FISH OIL; METOPROLOL; MVI [ASCORBIC ACID;DEXPANTHENOL;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE]. Past drug history included: Neosporin, reaction(s): "Known allergies: Neosporin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19, which included anti viral - covid-19 treatment product.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events and BNT162B2.
Dose 3 vaccination Pfizer-BioNTech, 03/11/2022, Lot FL3198. Within approximately three weeks after my vaccination, I started experience pain in my back in the lung area and issues with my breathing. I have seen my general practitioner who now have me seeing a pulmonologist who is ordering test on 04/27/2022 and 05/05/2022. I have received breathing test to rule out asthma and emphysema and that their was no obstruction. These upcoming test is being used to determined what the restriction is.
While receiving the Adacel IMZ the patient said she felt the needle hit her nerve. She said after that she has pain from her arm to the back of her neck on the right side above the shoulder. She states that is hurts when she sweeps the floor. Patient stated that she has not seen her doctor about the pain. She said it is slowly getting better.
My original vaccinations were Moderna back in April and May of 2021. Decided to have the Pfizer booster shot. One day following the Pfizer booster shot, started itching on the right side of my body (chest, arm, and scalp). Booster was given in right arm. Also, blisters, similar to poison ivy, developed on the right side of my nose. Now, four days later, blisters are very pronounced and itchy. Scalp and chest still a little itchy. Right side of nose feels "tight" - probably due to the blisters.
On first attempt at ID vaccine administration needle appeared to be too superficial and once vaccinator pushed the plunger the vaccine leaked onto the client's arm.  Dose successfully administered using ID method on 2nd attempt - 2 inches away from 1st attempt.
Rash on both arms, neck, face and chest. Some blurriness in eyes, pain at injection site and a headache.
Sore injection site arm; Headache; Very tired; Patient received his second Moderna Covid-19 vaccine 24 days later; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received his second Moderna Covid-19 vaccine 24 days later), VACCINATION SITE PAIN (Sore injection site arm), HEADACHE (Headache) and FATIGUE (Very tired) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No medical history were reported.  The patient's past medical history included Cancer.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received his second Moderna Covid-19 vaccine 24 days later). On 28-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore injection site arm) and FATIGUE (Very tired). 28-Feb-2021, the patient experienced HEADACHE (Headache). On 02-Mar-2021, HEADACHE (Headache) and FATIGUE (Very tired) had resolved. On 06-Mar-2021, VACCINATION SITE PAIN (Sore injection site arm) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received his second Moderna Covid-19 vaccine 24 days later) had resolved.            No concomitants medication were provided. No treatment medication were provided. No lab data has been provided by the reporter.   This case was linked to MOD-2021-265483, MOD-2021-309134 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Sep-2021: Significant follow-up appended - Dose 2 date and batch no. updated and medical history update received.
Had 5 (periods instead of 3) in 3 months, one lasting 13 days. All were heavier and more blood clots then normal. My cycle was 28 days and now seems to be 21 days.
CLIENT BEHIND ON VACCINE SCHEDULE. GIVEN PEDIARIX AND IPV SAME DAY INADVERTENLY.
Not feeling well; Cold; Cough; Stuffiness; Fever; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (Not feeling well), FEELING COLD (Cold), COUGH (Cough), MUSCULOSKELETAL STIFFNESS (Stuffiness) and PYREXIA (Fever) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced MALAISE (Not feeling well), FEELING COLD (Cold), COUGH (Cough), MUSCULOSKELETAL STIFFNESS (Stuffiness) and PYREXIA (Fever). At the time of the report, MALAISE (Not feeling well), FEELING COLD (Cold), COUGH (Cough), MUSCULOSKELETAL STIFFNESS (Stuffiness) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information included Tylenol. Action taken with mRNA-1273 in response to the event was unknown
Patient experience headache after receving vaccine on 7/21/21. Took pain med (Tylenol alternating Ibuprofen 2 days after with no relief). 7 days later still have ache on right side of head along with pain in right side of eye and ear.
sore arm; This is a spontaneous report from a contactable consumer (patient herself). A 45-year-old female patient received first dose of bnt162b2 (BNT162B2 also reported as COVID-19 vaccine, lot/batch number and expiry date were not reported), via an unspecified route of administration on unspecified date at single dose, for Covid-19 immunisation. Medical history included rheumatoid arthritis and allergic reactions (unspecified). Concomitant medications were not reported.  After receiving the first dose of the vaccination the patient experienced a sore arm on an unspecified date. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
After the shot, when I was waiting in the monitoring lot, I felt intense pain in my arm and it made my muscles tense all through my neck. I also got dizzy and lightheaded. The girl in the car next to me had waved over one of the attendants as well because she was feeling weird too. I got home and had the worst headache I've ever had and felt flu like symptoms and very weak. The next day at work I was so sick I had to go home. I was puking and had diarrhea  over and over for a few hours. I also felt lightheaded and dizzy and weak. Also had the headache. I was getting chills as well once I got home. Today I just feel very weak and just "off".
This resident had already received a Pfizer Bivalent on 9/22/2022 but did not remember
severe headache 2 weeks later, dizzy spells for about a week. Had a CT scan and found out it was a stroke.
Burning of my heart; Chest pain, after the second shot, it was an 8/10 on the pain scale; Accompanied by palpitations and pounding heartbeat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 10Sep2021 13:30 (Batch/Lot number: unknown) at the age of 43 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "Plantar fasciitis" (unspecified if ongoing); "gelatin" (unspecified if ongoing); "MSG allergy" (unspecified if ongoing); "xanthan gum allergy" (unspecified if ongoing); "acacia gum allergy" (unspecified if ongoing); "artificial flavors" (unspecified if ongoing); "carag allergy" (unspecified if ongoing). Concomitant medication(s) included: TYROSINE; GTA FORTE II; SELENIUM. Past drug history included: Bactrim, reaction(s): "known allergies: Bactrim"; Z-pak, reaction(s): "known allergies: Z-pak"; Codeine, reaction(s): "known allergies:codeine"; Phenergan, reaction(s): "known allergies: Phenergan". Vaccination history included: Bnt162b2 (1st Dose, administration date=20Aug2021,, administration time=15:00 , vaccine location=Left arm), administration date: 20Aug2021, when the patient was 43 years old, for Covid-19 Immunization, reaction(s): "Burning of my heart", "chest pain". The following information was reported: BURNING SENSATION (non-serious) with onset 10Sep2021, outcome "recovered" (2021), described as "Burning of my heart"; CHEST PAIN (non-serious) with onset 10Sep2021, outcome "recovered" (15Sep2021), described as "Chest pain, after the second shot, it was an 8/10 on the pain scale"; PALPITATIONS (non-serious) with onset 10Sep2021, outcome "recovered" (Sep2021), described as "Accompanied by palpitations and pounding heartbeat". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of burning sensation, chest pain, palpitations.  Additional Information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, patient was not diagnosed with COVID-19. Patient received other medications within 2 weeks of vaccination included Pro. Burning of her heart and chest pain. she had it more mildly after the first shot for about 2 days after the shot. After the second shot, it was an 8/10 on the pain scale and lasted from Friday 10Sep21 to Wednesday 15Sep21. It was accompanied by palpitations and pounding heartbeat at times. The patient received treatment for the adverse reactions with ibuprofen for every 4 hours. Since the vaccination, patient had been tested for COVID-19 on 04Oct2021 via nasal swab test, result was negative.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Saturday night around 9:45 my hands and arms began itching.  Then i noticed they had broken out in a red rash with whelps beginning on my arms.  It then began breaking out on my face and legs.  I took 25 mg of benadryl.  The rash continued to spread so  I went to the ER. They administered prednisone, pepcid, and benadryl.  After about 1 hour the itching was better and the rash began to fade but it didn't go away.  The ER sent my home with a predisone dose pack for 6 days and to take 50 mg  benadryl every 6 hours.  When i awakened this morning I had the rash on other sites on my arms, legs and stomach and in my right eye, it was red and a little swollen.  I took the first day's dose of prednisone and 50 mg benadryl and 20 mg of famotidine. After about 30 mins to 1 hour the itching and redness improved but has not completely gone.
Patient returned to clinic @1410 showing signs of anaphylaxis. Epinephrine was administered @1415. Vitals signs were documented in health system. Patient was transferred by EMS to Medical Center.
severe persistent deep muscle (almost like bone) ache, headache, chills so bad scared to even take a hot shower,, low grade fever (100.1 max), malaise, fatigue, joint ache, intermittent sharp muscle twinges, absolute loss of appetite, dry cracked throat, aversion to sound. unable to perform basic activities of daily living......taking motrin 600 - 800mg three times a day, this is the third day........horrible horrible experience i believe from the shingles vaccine. had the tdap vaccine in the past without any issues.
Pt. states that after receiving the 1st dose of Phizer 11/04/2021, started experiencing symptoms 20mins later of nausea, swelling in the left arm to the elbow, red rashy lines from the (left) forearm to the elbow, and blurry vision. Pain in and around the injection site, left arm  soreness, and chest tightness. Primary (APN) visit/communications 11/05/2021 with no recommendations.
Fever; Chills; Body aches; Headache; Sore arm where injection was; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 15:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and anxiety. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included citalopram (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN) for unknown indications, from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 at 15:45 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 04:30, the patient experienced fever, chills, body aches, headache, sore arm where injection was and fatigue, lasted a little over 24 hours except for headache which lasted more like 36 hours or so. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, body aches, headache, sore arm where injection was and fatigue was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Ct reports tenderness & redness last night. TC to this RN am stating area red & warm & hard at injection site seen at 4:45 pm area warm & hard 50 mm x 50 mm. Encourage apply moist compress & seek medically attention if S&S increased.
This case was reported by a physician via call center representative and described the occurrence of therapy non-responder in a patient who received ENERGIX B. Co-suspect products included TWINRIX. On an unknown date, the patient received ENGERIX B at an unknown dose and TWINRIX at unknown dose. On an unknown date, an unknown time after receiving ENGERIX B and TWINRIX, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown. Additional information provided: 3 patients at this practice got either ENGERIX or TWINRIX per schedule. Titers were checked timely but did not have response to hep B. This case is one of the 3 cases reported by the same reporter for the same vaccine.
Janssen COVID-19Vaccine EUA  Between 8 pm the 10th and 4 am the 11th, experienced increased heart rate averaging around 120-140 with a couple of episodes that felt like heart attacks when heart rate jumped to 140 (palpitations, nausea, cold sweats, stomach pain, lightheaded, weak). Collapsed on the floor due to symptoms.
I received a Moderna COVID-19 booster on 6/7/2022. On 10/4/2022, my wife and I were on a vacation out of town. I developed a fever, body aches, runny nose, sneezing, and coughing. I basically felt like I had a bad cold. I took a home test for COVID-19 and got a positive result. I then went to one of the local clinics to have the diagnosis confirmed. I took another rapid test, which also yielded a positive result. The clinic staff basically advised us to self-isolate and to stay hydrated. They didn't prescribe any medication, so I treated my symptoms with an OTC pain reliever like Tylenol, which helped. As soon as I got my diagnosis, we headed home in our car. I started to feel a little better once we got back home. By then, the congestion and the aches and pains had subsided. I continued to get better. I took another home antigen test on 10/18/2022 and got a negative result. I then took another on 10/20/2022 and got another negative result. At the time of this writing, I feel that I have made a complete recovery.
mom stated p/shots on 17MAR93 pt was cranky & again cranky on the 18th; pt had no fever; on the 19th @ lunchtime devel sz, woud stare off for about 1 minute, then fall asleep;
sore arm; chills; exhaustion so bad it almost bordered nausea; This is a spontaneous report from a contactable consumer or other non-HCP. A 77-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via an unspecified route of administration in left arm on 04Feb2021 at 07:00 as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. No covid test post vaccination. No other vaccine in four weeks. The patient didn't receive other medication in two weeks. On 04Feb2021 at 22:00, the patient experienced sore arm, chills, and exhaustion so bad it almost bordered nausea. The patient did not receive any treatment for the adverse events. The outcome of events was recovered.
Pt vaccinated with DTP notice signs of limpness for 2 wks. Later started having convulsion seizure about 4 wks after the shot they (convuls)stopped except for when pt gets fevers w/ear infection.
Patient developed intermittent afib after first dose but was not seen by a physician at that time, the events were recorded on his smart watch.  After second dose, patient went into continuous afib with a blood pressure of 200/120 and a pulse around 200.  Went to the local emergency room and was put on cardiac meds, had an ecg that confirmed the diagnosis.  Was seen by the primary the next morning and put on a different cardiac med.  Still no change to the afib.
Flushing/sweating, dizziness; BP 146-156/80; HR 69-79; RR 16-18, SpO2 97%
Second dose received more than 36 days after the first dose.; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received more than 36 days after the first dose.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received more than 36 days after the first dose.). On 15-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received more than 36 days after the first dose.) had resolved.            Concomitant medication was not reported. Treatment information was not provided.
First shot was severe itching. Second shot was horrible. Headache,fever, chills , every bone in body hurt, fatigue, feeling like a balloon without air
This spontaneous report was received from a Nurse regarding a 4-year old female patient. The patient's concurrent condition, medical history, drug reactions/allergies and concomitant medications were not reported. It was reported that the patient was well child at the time of vaccination. On 13-APR-2018 the patient was vaccinated with first dose (reported as one) ROTATEQ (Lot # N022174 dose 1, oral at private doctor's office or hospital with public funds) for prophylaxis (drug administered to patient of inappropriate age). Other suspect therapies included FLUZONE (lot # U182AE dose 1 through intramuscular) for prophylaxis on 13-APR-2018. There was no temperature excursion occur because of a reading from digital data logger. It was reported that the medication error occurred at the time of dispensing (Drug dispensing error). No adverse effect reported. No product quality compliant (PQC) was reported.
Numbness, tingling , swelling in hands, fingers  and arms. Twitching/shaking  in arms , legs, hands during the night especially and in morning.
Awoke 2/3/11 with sudden-onset Left-sided facial weakness/paralysis.  Diagnosed by her personal physician on 2/3/11 with Bell's Palsy; treated by her PMD with Prednisone 20mg PO BID x6 days.  Individual is on day 4 of treatment, and is still currently having symptoms.
Dizziness, blurred vision, nausea.  Taken to ED from vax site. Given IVF, Zofran inj.